Improving Traumatic Brain Injury Rehabilitation for Patients Worldwide

We aim to create therapeutics that protect and restore neural function after traumatic brain injury.


Who We Are

We are a pre-seed pharmaceutical start-up with a mission of easing the pain of rehabilitation after traumatic brain injury. The founder, Lyeth, went through a brain tumor resection at the age of 13 for an astrocytoma brain tumor in his cerebellum. After the extensive and costly rehabilitation process, he set his life mission to easing the pain of others who are going through similar situations.